A Closer Look at Gilenya – The First Oral Treatment for MS

Posted: Published on September 28th, 2011

This post was added by Dr Simmons



MSAA's Chief Medical Officer Dr. Jack Burks answers 6 important questions about Gilenya, the new oral medication for MS, including: * what is Gilenya * how it differs from current FDA-approved disease modifying therapies? * side effects * who might be a candidate to take it * pregnancy issues

Read the original post:
A Closer Look at Gilenya - The First Oral Treatment for MS

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.